Lipid Profile Abnormalities in ß-Thalassemia Patients with Multiple Blood Transfusions

Authors

  • Syeda Sabahat Haidar
  • Mehvish Sana
  • Rukhsana Tumrani
  • Farwa Shafqat

DOI:

https://doi.org/10.51985/JBUMDC2022160

Keywords:

Atherosclerosis, Blood transfusion, Iron overload, Lipid profile, ß-Thalassemia

Abstract

Objective: To determine lipid profile abnormalities in ß -thalassemia patients with multiple blood transfusions in tertiary care hospital.

 

Study design and setting: This cross-sectional study was conducted in Chemical Pathology section, Pathology department Sheikh Zayad Medical College and Hospital Rahim Yar Khan from 1st July 2022 to 31st October 2022.

 

Methodology: 110 patients aged 1 to 18 years from both genders enrolled in Thalassemia center of Sheikh Zayed Hospital with multiple blood transfusions were included in study using convenient sampling technique. Patients with cardiac disease, diabetes mellitus and family history of lipid disorders were excluded. Blood samples collected from thalassemia patients were subjected to estimation of serum total cholesterol, serum triglycerides, HDL-C, and LDL-C. Data was recorded on predesigned performa. Post stratification t test was applied and p value <0.05 was considered significant.

 

Results: Mean age of the patients was 7.77±3.846 years. Mean serum cholesterol, serum triglyceride, HDL-C and LDLC were 89.15±20.33mg/dl, 211.00±77.78mg/dl, 21.01±6.554mg/dl and 29.79±17.02 respectively. Mean triglyceride and LDL-C level was higher in patients with weekly transfusion than patients undergoing monthly transfusion with statistically significant difference of triglycerides and LDL-C between two groups with p=0.002 and 0.023 respectively. Conclusion: We found that frequent blood transfusion causes lipid profile abnormalities in thalassemia patients. Lipid profile abnormalities should be screened frequently in ß-thalassamia patients with multiple blood transfusions.

References

Ragab SM, Safan MA, Sherif AS. Lipid profiles in ß

thalassemic children. Menoufia Med J 2014; 27(1):66 DOI:

https://doi.org/10.4103/1110-2098.132749

Suman R, Sanadhya A, Meena P, Singh J, Jain R, Meena S.

Lipid profile in children of ß-thalassemia mayor and their

correlation with serum ferritin. Int J Contemp Pediatr 2017

Mar; 4(2):543-7

Origa R. ß-Thalassemia. Genet Med 2017 ;19(6):609-19 DOI:

https://doi.org/10.1038/gim.2016.173

Ali S, Mumtaz S, Shakir HA, Khan M, Tahir HM, Mumtaz

S, et al. Current status of beta-thalassemia and its treatment

strategies. Mol Genet Genomic Med 2021;9(12):e1788 DOI:

https://doi.org/10.1002/mgg3.1788

Akhtar S, Nasir JA, Hinde A. The prevalence of hepatitis C

virus infection in ß-thalassemia patients in Pakistan: a

systematic review and meta-analysis. BMC Public Health

; 20(1):1-9 DOI: https://doi.org/10.1186/s12889-020-

-5

Wibowo TS, Ashariati A, Bintoro S, Soeslistijo SA. Serum

Ferritin Levels and Lipid Profile in Patients with TransfusionDependent Beta and Beta/HbE Thalassemia. Int J Pharm Res

; 12(4)

Balcý YI, Ünak Þ, Gümrük F. Serum Lipids in Turkish Patients

with ß-Thalassemia Major and ß-Thalassemia Minor. Turk J

Hematol 2016; 33:71-83

Maira D, Cassinerio E, Marcon A, Mancarella M, Fraquelli

M, Pedrotti P, et al. Progression of liver fibrosis can be

controlled by adequate chelation in transfusion-dependent

thalassemia (TDT). Ann Hematol 2017;96:1931-6 DOI:

https://doi.org/10.1007/s00277-017-3120-9

Taher AT, Saliba AN. Iron overload in thalassemia: different

organs at different rates. Hematology Am Soc Hematol Educ

Program 2017; 2017(1):265-71 DOI: https://doi.org/10.1182

/asheducation-2017.1.265

Nandi S, Samanta S, Mondal T, Halder S. Study of lipid

profile in ß thalassemia major pediatric patients with multiple

blood transfusion and its correlation with serum ferritin level

in tertiary care hospital in Kolkata. Int J Community Med

Public Health 2021; 8(4):1778 DOI: https://dx.doi.org/

18203/ 2394-6040.ijcmph20211233

Jabbar HK, Hassan MK, Al-Naama LM. Lipids profile in

children and adolescents with ß-thalassemia major. Hematol

Transfus Cell Ther 2022 DOI: https://doi.org/10. 1016/

j.htct.2022.09.1277

Saleh KK, Abdullah SR, Mekha RE. Estimation of Serum

Homeostasis Model Assessment-Insulin Resistance and Lipid

Profile in Beta-thalassemia Major Patients and their Correlation

with Iron Overload in Koya City. Polytechnic J 2019; 9(2):125-

DOI: https://doi.org/10.25156/ptj.v9n2y2019.pp125-132

Daswani P, Garg K. Lipid profile in?-thalassemia major

children and its correlation with various parameters. Indian

J Child Health 2021; 8(1):26-31 DOI: https://doi.org/10.32677

/IJCH.2021.v08.i01.005

Kumar T, Basu S, Kundu R, Majumdar I, Mukherjee D. Lipid

profile in children with thalassemia: A prospective

observational study from eastern India. Indian pediatrics 2020

Nov; 57:1072-3 DOI: https://doi.org/10.1007/s13312-020-

-2

Dey A, Sandip C, Arya S. dkk. Correlation of serum lipid

profile with serum iron, TIBC & ferritin levels in beta

thalassemia major patients. Eur J Biol and Med Sci Res 2016;

:17-26

Mashaali JK, Obed FA, Thair NT. Lipid Profile in Iraqi

Children with ß-thalassemia Major. Iraqi J Hematol 2014;

(2):108

Ashar S, Sultan S, Irfan SM, Sheeraz A. Serum fasting lipid

profile in children and adolescents with ß-thalassaemia major

in southern Pakistan. Malay J Pathol 2015; 37(3)

Asif M, Rasheed A. Dyslipidemia in beta thalassemia major

patients. J Saidu Med Col 2015; 5(2):695-7

Inati A, Noureldine MA, Mansour A, Abbas HA. Endocrine

and bone complications in ß-thalassemia intermedia: current

understanding and treatment. BioMed Res Int 2015; 2015

DOI: https://doi.org/10.1155/2015/813098

Tamaddoni A, Nasseri E, Mohammadi E, Qujeq D, Zayeri

F, Zand H, et al. A double-blind randomized controlled trial

of curcumin for improvement in glycemic status, lipid profile

and systemic inflammation in ß-thalassemia major. J Herb

Med 2020;21:100324 DOI: https://doi.org/10.1016

/j.hermed.2019.100324

Setoodeh S, Khorsand M, Takhshid MA. The effects of iron

overload, insulin resistance and oxidative stress on metabolic

disorders in patients with ß-thalassemia major. J Diabetes

Metab Disord 2020; 19:767-74

Boudrahem-Addour N, Izem-Meziane M, Bouguerra K,

Nadjem N, Zidani N, Belhani M, et al. Oxidative status and

plasma lipid profile in ß-thalassemia patients. Hemoglobin

;39(1):36-41 DOI: https://doi.org/10.3109 /03630269.

979997

Casula M, Colpani O, Xie S, Catapano AL, Baragetti A. HDL

in atherosclerotic cardiovascular disease: in search of a role.

Cells 2021; 10(8):1869

Downloads

Published

2023-10-23

How to Cite

Haidar, S. S. ., Sana, M. ., Tumrani, R. ., & Shafqat, F. . (2023). Lipid Profile Abnormalities in ß-Thalassemia Patients with Multiple Blood Transfusions. Journal of Bahria University Medical and Dental College, 13(04), 296–9. https://doi.org/10.51985/JBUMDC2022160

Issue

Section

Original Articles